We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1un5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1un5.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1un5.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1un5| PDB=1un5 | SCENE= }}
{{STRUCTURE_1un5| PDB=1un5 | SCENE= }}
-
'''ARH-II, AN ANGIOGENIN/RNASE A CHIMERA'''
+
===ARH-II, AN ANGIOGENIN/RNASE A CHIMERA===
-
==Overview==
+
<!--
-
Human angiogenin (Ang) is a potent inducer of blood vessel formation and is a member of the pancreatic ribonuclease superfamily. Its enzymatic activity is unusually weak and biased toward cleavage after cytidine nucleotides. As part of an ongoing investigation into the structural basis of Ang's characteristic activity, we have determined the crystal structures of three Ang variants having novel activity. (i) The structure of T44D-Ang indicates that Asp44 can participate directly in pyrimidine binding and that the intrinsic hydrogen-bonding capability of this residue largely governs the pyrimidine specificity of this variant. Unexpectedly, the mutation also causes the most extensive disruption of the C-terminus seen in any Ang variant thus far. This allows the side chain of Arg101 to penetrate the B(1) site, raising the possibility that it participates in substrate binding as occurs in ribonuclease 4. (ii) The structure of T80A-Ang supports the view that Thr80 plays little role in maintaining the obstructive conformation of the C-terminus and that its participation in a hydrogen bond with Thr44 selectively weakens the interaction between Thr44 and N3 of cytosine. (iii) ARH-II is an angiogenin/RNase A chimera in which residues 38-41 of Ang are replaced with the corresponding residues (38-42) of RNase A. Its structure suggests that the guest segment influences catalysis by subtle means, possibly by reducing the pK(a) of the catalytic lysine. The loss of angiogenic activity is not attributable to disruption of known cell-binding or nuclear translocation sites but may be a consequence of the chimera's enhanced ribonucleolytic activity.
+
The line below this paragraph, {{ABSTRACT_PUBMED_14756559}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 14756559 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_14756559}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Hybrid]]
[[Category: Hybrid]]
[[Category: Pancreatic ribonuclease]]
[[Category: Pancreatic ribonuclease]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 11:27:23 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 13:58:13 2008''

Revision as of 10:58, 29 July 2008

Image:1un5.png

Template:STRUCTURE 1un5

ARH-II, AN ANGIOGENIN/RNASE A CHIMERA

Template:ABSTRACT PUBMED 14756559

About this Structure

1UN5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41., Holloway DE, Chavali GB, Hares MC, Baker MD, Subbarao GV, Shapiro R, Acharya KR, Biochemistry. 2004 Feb 10;43(5):1230-41. PMID:14756559

Page seeded by OCA on Tue Jul 29 13:58:13 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1un5"
Personal tools